A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 85,088 shares of PCVX stock, worth $8.98 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
85,088
Previous 85,088 -0.0%
Holding current value
$8.98 Million
Previous $5.81 Million 10.53%
% of portfolio
0.01%
Previous 0.01%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$59.79 - $81.05 $3.89 Million - $5.27 Million
-65,000 Reduced 43.31%
85,088 $5.81 Million
Q4 2023

Feb 14, 2024

BUY
$45.35 - $63.41 $816,300 - $1.14 Million
18,000 Added 13.63%
150,088 $9.43 Million
Q3 2023

Nov 14, 2023

BUY
$46.0 - $53.1 $3.31 Million - $3.82 Million
72,000 Added 119.82%
132,088 $6.73 Million
Q2 2023

Aug 14, 2023

SELL
$34.66 - $54.07 $13 Million - $20.3 Million
-374,912 Reduced 86.19%
60,088 $3 Million
Q1 2023

May 15, 2023

SELL
$36.27 - $47.2 $13.1 Million - $17 Million
-360,000 Reduced 45.28%
435,000 $16.3 Million
Q4 2022

Feb 14, 2023

BUY
$20.58 - $47.95 $14.3 Million - $33.3 Million
695,000 Added 695.0%
795,000 $38.1 Million
Q3 2022

Nov 14, 2022

BUY
$21.69 - $28.53 $1.02 Million - $1.34 Million
47,100 Added 89.04%
100,000 $2.4 Million
Q2 2022

Aug 15, 2022

BUY
$17.68 - $26.58 $935,272 - $1.41 Million
52,900 New
52,900 $1.15 Million

Others Institutions Holding PCVX

About Vaxcyte, Inc.


  • Ticker PCVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,315,100
  • Market Cap $6.26B
  • Description
  • Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...
More about PCVX
Track This Portfolio

Track Adage Capital Partners Gp, L.L.C. Portfolio

Follow Adage Capital Partners Gp, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.